THE US Food and Drug Administration has approved Spinraza (nusineren), the first drug approved to treat children and adults with spinal muscular atrophy (SMA) - a rare and often fatal genetic disease.
Spinraza is administered as a lumbar injection - see fda.gov.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 Jan 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 Jan 17
